MARKET

VKTX

VKTX

Viking Therapeutics Inc
NASDAQ
38.55
-0.02
-0.05%
After Hours: 38.70 +0.15 +0.39% 19:59 12/05 EST
OPEN
38.34
PREV CLOSE
38.57
HIGH
39.48
LOW
38.05
VOLUME
2.75M
TURNOVER
--
52 WEEK HIGH
52.81
52 WEEK LOW
18.92
MARKET CAP
4.36B
P/E (TTM)
-18.1994
1D
5D
1M
3M
1Y
5Y
1D
Viking Therapeutics: Prepping For A Critical 2026
Seeking Alpha · 11h ago
Noteworthy Thursday Option Activity: GM, VKTX, LUNR
NASDAQ · 2d ago
What's Up With The Jump In Viking Therapeutics Stock?
Benzinga · 2d ago
LLY Lowers Prices of Zepbound Vials for Cash Buyers on DTC Website
NASDAQ · 4d ago
VKTX Stock Rises 34% in Three Months: Here's What You Should Know
NASDAQ · 5d ago
Weekly Report: what happened at VKTX last week (1124-1128)?
Weekly Report · 5d ago
Wall Street Analysts Think Viking Therapeutics (VKTX) Is a Good Investment: Is It?
NASDAQ · 11/28 14:30
Novo Nordisk Seeks Extra-Fast Nod From FDA for Higher Dose of Wegovy
NASDAQ · 11/27 16:24
More
About VKTX
Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company that is focused on the development of therapies for the treatment of metabolic and endocrine disorders. Its clinical programs include VK2735, a novel dual agonist of the glucagon-like peptide 1 and glucose-dependent insulinotropic polypeptide receptors for the potential treatment of various metabolic disorders. It is evaluating an oral formulation of VK2735 in a Phase II trial. It is also developing VK2809, a novel, orally available, small molecule selective thyroid hormone receptor beta agonist for the treatment of lipid and metabolic disorders. Its newest program is evaluating a series of internally developed dual amylin and calcitonin receptor agonists for the treatment of obesity and other metabolic disorders. In the rare disease space, it is developing VK0214, a novel, orally available, small molecule selective thyroid hormone receptor beta agonist for the potential treatment of X-linked adrenoleukodystrophy.

Webull offers Viking Therapeutics Inc stock information, including NASDAQ: VKTX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, VKTX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading VKTX stock methods without spending real money on the virtual paper trading platform.